Montana Aerospace Valuation
Is AEROZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AEROZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: AEROZ (CHF15.44) is trading below our estimate of fair value (CHF48.81)
Significantly Below Fair Value: AEROZ is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AEROZ?
Key metric: As AEROZ is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
What is AEROZ's PS Ratio? | |
---|---|
PS Ratio | 0.6x |
Sales | €1.61b |
Market Cap | €1.03b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.9x |
Enterprise Value/EBITDA | 8.7x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does AEROZ's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1.7x | ||
SNR Senior | 0.6x | 5.7% | UK£591.3m |
CHG Chemring Group | 2x | 8.3% | UK£980.1m |
CHRT Cohort | 2x | 13.5% | UK£413.1m |
AVON Avon Technologies | 2x | 5.9% | UK£427.1m |
AEROZ Montana Aerospace | 0.6x | 5.7% | CHF 962.3m |
Price-To-Sales vs Peers: AEROZ is good value based on its Price-To-Sales Ratio (0.6x) compared to the peer average (1.7x).
Price to Sales Ratio vs Industry
How does AEROZ's PS Ratio compare vs other companies in the European Aerospace & Defense Industry?
3 Companies | Price / Sales | Estimated Growth | Market Cap |
---|---|---|---|
3 Companies | Estimated Growth | Market Cap | |
---|---|---|---|
Price-To-Sales vs Industry: AEROZ is good value based on its Price-To-Sales Ratio (0.6x) compared to the European Aerospace & Defense industry average (1.5x).
Price to Sales Ratio vs Fair Ratio
What is AEROZ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.6x |
Fair PS Ratio | 1x |
Price-To-Sales vs Fair Ratio: AEROZ is good value based on its Price-To-Sales Ratio (0.6x) compared to the estimated Fair Price-To-Sales Ratio (1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | CHF 15.44 | CHF 22.32 +44.6% | 16.3% | CHF 27.90 | CHF 17.94 | n/a | 5 |
Nov ’25 | CHF 15.04 | CHF 23.35 +55.3% | 20.3% | CHF 31.78 | CHF 18.46 | n/a | 5 |
Oct ’25 | CHF 20.10 | CHF 24.28 +20.8% | 20.8% | CHF 31.80 | CHF 18.19 | n/a | 5 |
Sep ’25 | CHF 19.12 | CHF 24.37 +27.4% | 20.8% | CHF 32.01 | CHF 18.31 | n/a | 5 |
Aug ’25 | CHF 18.65 | CHF 24.15 +29.5% | 20.4% | CHF 32.03 | CHF 17.79 | n/a | 5 |
Jul ’25 | CHF 19.08 | CHF 23.66 +24.0% | 20.7% | CHF 31.54 | CHF 17.36 | n/a | 5 |
Jun ’25 | CHF 19.52 | CHF 23.22 +19.0% | 22.1% | CHF 32.04 | CHF 17.83 | n/a | 5 |
May ’25 | CHF 17.68 | CHF 21.92 +24.0% | 23.5% | CHF 32.05 | CHF 17.79 | n/a | 5 |
Apr ’25 | CHF 16.87 | CHF 22.33 +32.4% | 26.9% | CHF 32.07 | CHF 15.22 | n/a | 5 |
Mar ’25 | CHF 15.41 | CHF 22.33 +44.9% | 26.9% | CHF 32.07 | CHF 15.22 | n/a | 5 |
Feb ’25 | CHF 16.49 | CHF 22.42 +35.9% | 27.1% | CHF 31.99 | CHF 15.18 | n/a | 5 |
Jan ’25 | CHF 17.62 | CHF 22.59 +28.2% | 28.8% | CHF 33.02 | CHF 14.96 | n/a | 5 |
Dec ’24 | CHF 15.52 | CHF 22.05 +42.1% | 27.2% | CHF 33.01 | CHF 15.32 | n/a | 5 |
Nov ’24 | CHF 11.66 | CHF 21.85 +87.4% | 27.5% | CHF 31.64 | CHF 15.32 | CHF 15.04 | 4 |
Oct ’24 | CHF 11.34 | CHF 22.25 +96.2% | 28.0% | CHF 32.34 | CHF 15.30 | CHF 20.10 | 4 |
Sep ’24 | CHF 13.54 | CHF 24.76 +82.9% | 19.2% | CHF 31.88 | CHF 19.92 | CHF 19.12 | 4 |
Aug ’24 | CHF 13.60 | CHF 24.97 +83.6% | 18.7% | CHF 31.74 | CHF 19.49 | CHF 18.65 | 4 |
Jul ’24 | CHF 14.48 | CHF 24.97 +72.5% | 18.7% | CHF 31.74 | CHF 19.49 | CHF 19.08 | 4 |
Jun ’24 | CHF 14.04 | CHF 26.16 +86.3% | 19.3% | CHF 31.97 | CHF 19.63 | CHF 19.52 | 3 |
May ’24 | CHF 16.30 | CHF 26.40 +62.0% | 18.7% | CHF 31.93 | CHF 19.96 | CHF 17.68 | 3 |
Apr ’24 | CHF 14.84 | CHF 26.48 +78.4% | 18.8% | CHF 32.12 | CHF 20.01 | CHF 16.87 | 3 |
Mar ’24 | CHF 17.48 | CHF 26.38 +50.9% | 18.7% | CHF 31.97 | CHF 19.98 | CHF 15.41 | 3 |
Feb ’24 | CHF 16.90 | CHF 26.25 +55.3% | 23.8% | CHF 32.51 | CHF 20.00 | CHF 16.49 | 2 |
Jan ’24 | CHF 14.44 | CHF 28.77 +99.2% | 24.4% | CHF 35.22 | CHF 19.03 | CHF 17.62 | 3 |
Dec ’23 | CHF 13.42 | CHF 28.77 +114.4% | 24.4% | CHF 35.22 | CHF 19.03 | CHF 15.52 | 3 |
Nov ’23 | CHF 11.52 | CHF 30.45 +164.3% | 26.7% | CHF 37.09 | CHF 19.02 | CHF 11.66 | 3 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
Babcock International Group
UK£2.6b
Engages in the design, development, manufacture, and integration of specialist systems for aerospace, defense, and security in the United Kingdom, rest of Europe, Africa, North America, Australasia, and internationally.
BABL
UK£5.16
7D
-1.0%
1Y
30.5%
Aalberts
€3.8b
Offers mission-critical technologies for aerospace, automotive, building, and maritime sectors.
0NX1
€34.35
7D
0.9%
1Y
-5.6%
Renold
UK£97.5m
Engages in the manufacture and sale of high precision engineered products and solutions in the United Kingdom, rest of Europe, the United States, Canada, Australasia, China, India, and internationally.
RNO
UK£0.49
7D
6.1%
1Y
48.0%